Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity.
about
Effect of dronedarone on Na+, Ca2+ and HCN channels.A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation.The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome PatientsInhibitory effects of sevoflurane on pacemaking activity of sinoatrial node cells in guinea-pig heart.Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties.Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.Funny Current and Cardiac Rhythm: Insights from HCN Knockout and Transgenic Mouse ModelsHigh-throughput drug profiling with voltage- and calcium-sensitive fluorescent probes in human iPSC-derived cardiomyocytes.Ivabradine for the treatment of chronic heart failure.HCN Channels Modulators: The Need for Selectivity.I(f) blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytesHCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I(f) blockadeCentral neural alterations predominate in an insect model of nociceptive sensitization.Ethanol enhances human hyperpolarization-activated cyclic nucleotide-gated currents.HCN2 channels: a permanent open state and conductance changes.Molecular identity, ontogeny, and cAMP modulation of the hyperpolarization-activated current in vestibular ganglion neurons.The heart rate-lowering agent ivabradine inhibits the pacemaker current I(f) in human atrial myocytes.Role of ivabradine in management of stable angina in patients with different clinical profiles.Beta-Blocker Dose Up-Titration or Addition of Ivabradine in Stable Angina: More is Not Necessarily Better
P2860
Q33807062-14C7C67F-04CD-4C25-8173-0652CDC98058Q34034342-5ADA37A3-6839-4142-9131-1F2075D8FBC2Q35914816-9F5E09D8-2A9B-4B4B-ADD2-20B08BB955F5Q36110517-66731D63-1B41-4C54-9A66-EE0AAB3A6F46Q38062592-3BF3180A-3AFD-46A8-A583-7C2953E75666Q38127568-B639100A-ACAC-4910-90E4-99D645BFC9BCQ38142792-61F0E24D-FBB8-473E-B54F-4D608428E7A5Q38548809-08560070-635D-4ADD-BA6C-3CA3E566FEBFQ38769738-B883AC63-E350-4A46-8653-04658D72343DQ38769814-A5F85577-422F-4AE5-B7C9-AA4F23A1E921Q38774251-2F6542D9-7853-4891-A595-BA2A4BB46E7CQ40333918-DA280DE8-DB2C-4C14-9435-7386CCFEE0D6Q41875995-306D9B61-1457-4E33-BF20-8FDE0AF2AF4FQ41989489-9C01D4B4-81E5-4790-B39E-FF3E7E3A42FAQ42506466-0E163ED5-44B4-4DDA-BE88-FE6C208DC380Q42692929-81F810BB-DA57-4A5F-98FD-A0588847E917Q48428838-9817E823-A2AC-4F8B-96B8-58CAE2D5075DQ50914053-BCFBABEB-1569-43AB-9F33-8C0B5B0917FEQ54961020-4D9223B0-AAFD-43EE-A539-1F76828895D3Q58645702-FCEB8197-3519-4BCB-A9CE-BCBFA2881EE8
P2860
Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Use-dependent inhibition of hH ...... duction in pacemaker activity.
@ast
Use-dependent inhibition of hH ...... duction in pacemaker activity.
@en
type
label
Use-dependent inhibition of hH ...... duction in pacemaker activity.
@ast
Use-dependent inhibition of hH ...... duction in pacemaker activity.
@en
prefLabel
Use-dependent inhibition of hH ...... duction in pacemaker activity.
@ast
Use-dependent inhibition of hH ...... duction in pacemaker activity.
@en
P2093
P2860
P356
P1476
Use-dependent inhibition of hH ...... duction in pacemaker activity.
@en
P2093
C Brunel-Jacquemin
J-A Boutin
J-L Peglion
J-P Guillaumin
J-P Vilaine
N Villeneuve
P Chomarat
P2860
P356
10.1038/SJ.BJP.0706940
P407
P577
2006-11-27T00:00:00Z